#460: Why healthtech still hasn't had its big exits

This week, James is joined by Dr Sai Narimetla, an A&E doctor who simultaneously works in investment banking at SSG Capital, to ask why healthtech hasn't produced the exits that biotech and medical devices have. They get into fragmentation, why the deals that are happening don't make headlines, and what a clinical lens actually adds when you're diligencing a company. Connect with Sai: https://www.linkedin.com/in/sainarimetla/ Learn more about SSG Capital: https://www.ssgcapital.uk/ Apply to be a guest: https://www.thehealthtechpodcast.com Subscribe to Healthtech Pigeon: https://www.healthtechpigeon.com Get in touch with James: https://www.jamessomauroo.com This podcast was brought to you by SomX.